Accelerate Diagnostics Inc (AXDX)
0.9364
+0.04
(+4.04%)
USD |
NASDAQ |
May 08, 16:00
0.9364
0.00 (0.00%)
After-Hours: 18:46
Accelerate Diagnostics Revenue (Quarterly): 3.027M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.027M |
| September 30, 2023 | 3.299M |
| June 30, 2023 | 2.921M |
| March 31, 2023 | 2.812M |
| December 31, 2022 | 2.972M |
| September 30, 2022 | 2.96M |
| June 30, 2022 | 3.861M |
| March 31, 2022 | 2.958M |
| December 31, 2021 | 3.343M |
| September 30, 2021 | 3.122M |
| June 30, 2021 | 2.798M |
| March 31, 2021 | 2.518M |
| December 31, 2020 | 3.109M |
| September 30, 2020 | 3.588M |
| June 30, 2020 | 2.125M |
| March 31, 2020 | 2.342M |
| December 31, 2019 | 3.47M |
| September 30, 2019 | 2.271M |
| June 30, 2019 | 1.806M |
| March 31, 2019 | 1.75M |
| December 31, 2018 | 1.822M |
| September 30, 2018 | 1.355M |
| June 30, 2018 | 1.692M |
| March 31, 2018 | 0.801M |
| December 31, 2017 | 2.119M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.828M |
| June 30, 2017 | 0.699M |
| March 31, 2017 | 0.53M |
| December 31, 2016 | 0.039M |
| September 30, 2016 | 0.024M |
| June 30, 2016 | 0.02M |
| March 31, 2016 | 0.163M |
| December 31, 2015 | 0.022M |
| September 30, 2015 | 0.092M |
| June 30, 2015 | 0.019M |
| March 31, 2015 | 0.014M |
| December 31, 2014 | 0.079M |
| September 30, 2014 | 0.016M |
| June 30, 2014 | 0.013M |
| March 31, 2014 | 0.014M |
| December 31, 2013 | 0.012M |
| September 30, 2013 | 0.013M |
| June 30, 2013 | 0.007M |
| March 31, 2013 | 0.016M |
| October 31, 2012 | 0.0083M |
| July 31, 2012 | 0.0125M |
| April 30, 2012 | 0.0132M |
| January 31, 2012 | 0.0083M |
| October 31, 2011 | 0.202M |
| July 31, 2011 | 0.101M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.806M
Minimum
Jun 2019
3.861M
Maximum
Jun 2022
2.911M
Average
2.96M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Achieve Life Sciences Inc | -- |
| ENDRA Life Sciences Inc | -- |
| Tivic Health Systems Inc | 0.357M |
| Spectral AI Inc | 3.44M |
| Perspective Therapeutics Inc | -5.239M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.00M |
| Total Expenses (Quarterly) | 13.76M |
| EPS Diluted (Quarterly) | -0.81 |
| Enterprise Value | 43.11M |
| Gross Profit Margin (Quarterly) | 20.91% |
| Profit Margin (Quarterly) | -429.4% |
| Earnings Yield | -578.8% |
| Normalized Earnings Yield | -478.55 |